Global Healthcare Annual Global Healthcare Conference Notes From Investment Banker Panel

This report provides key insights from a GS Investment Banker panel on the state of the healthcare sector, highlighting robust M&A growth and the complex integration of AI technologies.

Key Takeaways

• 1.Biopharma M&A activity has accelerated significantly, reaching $100bn YTD compared to $50bn in 2025, with large biotech acquirers targeting niche therapeutic areas.
• 2.AI is viewed as a significant tailwind in biopharma and diagnostics, though deployment costs, liability constraints, and integration hurdles in medical devices remain.
• 3.European healthcare companies are increasingly pursuing scale through bolt-on M&A and consolidation due to capital access constraints and pricing headwinds.

Table of Contents

• Key Takeaways
• Biopharma
• Medtech
• Life Sciences Tools & Diagnostics
• Europe Healthcare

Document Preview

Page 1 of 1

Subscribe for full accessStart Free Trial